Lot 1 - Linear Accelerators

This tender concerns the procurement of Lot 1, specifically focusing on Linear Accelerators. The scope of this procurement is to acquire state-of-the-art linear accelerator systems, which are critical medical devices used in radiation therapy for cancer treatment. These accelerators generate high-energy X-rays or electrons to precisely target and destroy cancerous cells while minimizing damage to surrounding healthy tissues. The tender likely involves the supply, installation, and potentially commissioning of these complex medical equipment. Key requirements may include specific technical specifications for beam energy, dose rate, treatment modes, imaging capabilities (such as cone-beam CT), and patient positioning systems. Furthermore, considerations for safety features, radiation shielding, quality assurance protocols, and compliance with international medical device standards are expected. The successful bidder will be responsible for ensuring the linear accelerators meet stringent performance criteria and are integrated seamlessly into existing hospital infrastructure. Training for medical personnel on the operation and maintenance of the equipment may also be a component of the contract. This procurement is vital for enhancing the radiotherapy services offered, improving patient outcomes, and advancing cancer care capabilities within the healthcare sector.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Medical Equipment. Located in Portugal, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.